11:07 AM EDT, 08/20/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending modestly lower late Tuesday morning, declining 0.22% to 1,454.49 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies Cellectis ( CLLS ) and Calliditas Therapeutics ( CALT ) , which rose 5.2% and 2.4%, respectively. They were followed by semiconductor company Sequans Communications ( SQNS ) and medical device maker EDAP TMS ( EDAP ) , which increased 1.4% and 1.2%, respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and accommodation booking company trivago (TRVG), which fell 3.8% and 3.4%, respectively. They were followed by petroleum refiner Equinor ( EQNR ) and internet browser company Opera (OPRA), which were down 1.4% and 0.8%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company TC Biopharm ( TCBP ) and biotech firm Autolus Therapeutics ( AUTL ) , which advanced 5.7% and 1.4%, respectively. They were followed by medical device maker Smith & Nephew ( SNN ) and pharmaceutical company AstraZeneca ( AZN ) , which were up 0.9% and 0.8%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana ( NCNA ) and Mereo BioPharma Group ( MREO ) , which lost 24% and 4%, respectively. They were followed by biopharmaceutical companies Amarin ( AMRN ) and Akari Therapeutics ( AKTX ) , which dropped 2.9% and 1.7%, respectively.